Hims & Hers Health: Q2 2026 Revenue Skyrockets by 38%, Sets $3.3B Full-Year Target

Global telehealth and wellness leader, Hims & Hers Health (NYSE: HIMS), has announced an impressive 38% year-over-year increase in its second-quarter 2026 revenue, reaching $753.2 million. This figure surpasses Wall Street’s estimates of $699 million by nearly 8%. The company’s customer base has expanded to nearly 2.9 million subscribers, marking a 19% increase compared to the same period last year. This growth reflects the rising consumer demand for accessible, digital-first healthcare and beauty solutions.

The company’s robust performance is attributed to its accelerating growth in the U.S. — with domestic revenue up 16% to $621.8 million — and a significant 17-fold surge in international revenue to $131.4 million. This international growth was primarily driven by the June 2026 acquisition of Australian telehealth platform, Eucalyptus. In addition, the monthly revenue per average subscriber rose 21% to $92. Management also highlighted AI-powered services and expanded product categories, including weight loss, skin care, and sexual health, as key growth drivers.

Following these results, Hims & Hers has revised its full-year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion. The company also expects an adjusted EBITDA between $275 million and $325 million. For Q3, the revenue target is set between $880 million to $900 million. The company maintains its long-term 2030 goals of at least $6.5 billion in revenue, reinforcing Hims & Hers’ position as a leading digital health and personal wellness platform for millions worldwide.

Source: Hims & Hers Investor Relations – Q2 2026 Financial Results (August 10, 2026)